Ligand Pharmaceuticals
LGND
LGND
265 hedge funds and large institutions have $3.04B invested in Ligand Pharmaceuticals in 2017 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 103 increasing their positions, 87 reducing their positions, and 23 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
265
Holders Change
+9
Holders Change %
+3.52%
% of All Funds
6.62%
Holding in Top 10
7
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+40%
% of All Funds
0.17%
New
34
Increased
103
Reduced
87
Closed
23
Calls
$26.7M
Puts
$5.51M
Net Calls
+$21.2M
Net Calls Change
+$45.6M
Top Buyers
Top Sellers
| 1 |
SCM
Scopia Capital Management
New York
|
-$52.8M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$16.9M |
| 3 |
GAM
Gotham Asset Management
New York
|
-$12.5M |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$10.5M |
| 5 |
State of New Jersey Common Pension Fund D
Trenton,
New Jersey
|
-$8.5M |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
FO
276
FT Options
Chicago,
Illinois
| – | -$379K | -5,740 | Closed |
|
|
AIM
277
Assured Investment Management
New York
| – | -$291K | -4,400 | Closed |
|
278
Janney Montgomery Scott
Philadelphia,
Pennsylvania
| – | -$259K | -3,929 | Closed |
|
|
FCBT
279
First Citizens Bank & Trust
Raleigh,
North Carolina
| – | -$231K | -3,501 | Closed |
|
|
BC
280
Brinker Capital
Berwyn,
Pennsylvania
| – | -$202K | -3,067 | Closed |
|
|
PAM
281
Paradigm Asset Management
New York
| – | -$53.2K | -806 | Closed |
|
|
QT
282
Quantbot Technologies
New York
| – | -$44K | -672 | Closed |
|
|
AIM
283
Arcadia Investment Management
Kalamazoo,
Michigan
| – | -$25K | -377 | Closed |
|
|
CAG
284
Crestwood Advisors Group
Boston,
Massachusetts
| – | -$6K | -88 | Closed |
|